GNRO — Geneuro SA Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- €1.02m
- €6.13m
Annual balance sheet for Geneuro SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 5.93 | 6.84 | 5.48 | 5.59 | 1.83 |
| Net Total Receivables | 1.17 | 0.669 | 1.23 | 1.48 | 0.162 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 7.28 | 7.66 | 9.87 | 9.09 | 2.33 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.677 | 1.44 | 1.22 | 0.993 | 0.742 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 9.4 | 10.5 | 12.5 | 11.5 | 6.36 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 11 | 2.33 | 3.07 | 3.31 | 6.25 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 14.6 | 5 | 7.69 | 10 | 20.1 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | -5.21 | 5.51 | 4.85 | 1.46 | -13.8 |
| Total Liabilities & Shareholders' Equity | 9.4 | 10.5 | 12.5 | 11.5 | 6.36 |
| Total Common Shares Outstanding |